About: Andrew Berchuck

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Andrew Berchuck Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) wetenschapper (nl) дослідник (uk) باحث (ar)
rdfs:label	Andrew Berchuck (en) Andrew Berchuck (sl)
skos:prefLabel	Andrew Berchuck (en) Andrew Berchuck (sl)
name	Andrew Berchuck (en) Andrew Berchuck (sl)
instance of	wds:Q114258102-991575F0-5920-4D93-A5E6-8DD5EE0F266C
instance of	Homo sapiens
occupation	wds:Q114258102-7A30E3C2-8589-4334-B79E-C948FC581221
CiNii Research ID	wds:Q114258102-4E9A50ED-C73F-4DF6-A728-3E9EC1B7245F
CONOR.SI ID	wds:Q114258102-16B6A36D-4002-45E0-9618-F156006C8DEA
languages spoken, written or signed	wds:Q114258102-C0211D5C-CAC8-4FED-97EF-50143AA89D72
sex or gender	wds:Q114258102-13ABB635-CA55-4123-B227-F16744450CB1
VIAF ID	wds:Q114258102-5B13BD7E-F077-476E-9748-6B48FF4EC39C
Library of Congress authority ID	wds:Q114258102-135E554E-AF58-4624-B357-6192F32C79FD
NACSIS-CAT author ID	wds:Q114258102-D83EF1FA-22D4-41B6-97E5-2382523D75E1
PLWABN ID	wds:Q114258102-9BD5EF44-C934-4D61-9F94-EE1299DB1C54
National Library of Israel J9U ID	wds:Q114258102-5D734BA3-132C-4E46-AD00-A381CECCF294
CiNii Research ID	https://cir.nii.ac.jp/crid/1140282266807122176.rdf
VIAF ID	http://viaf.org/viaf/71690215
Library of Congress authority ID	http://id.loc.gov/authorities/names/n96802517
NACSIS-CAT author ID	https://ci.nii.ac.jp/author/DA10906558#entity
occupation	researcher
CiNii Research ID	1140282266807122176
CONOR.SI ID	98129763
languages spoken, written or signed	English
sex or gender	male
VIAF ID	71690215
Library of Congress authority ID	n96802517
NACSIS-CAT author ID	DA10906558
PLWABN ID	9810661038805606
National Library of Israel J9U ID	987007383707405171
ORCID iD	wds:Q114258102-CF7194D7-80B2-4D5B-8EC8-4A5D406B2CF7
Dimensions author ID	wds:Q114258102-1E56483B-E548-46C1-8315-5CEDC0002A96 wds:Q114258102-28287D93-39AF-44F0-8457-8A98C1DA4705 wds:Q114258102-6BABD355-56D8-476F-BE9C-2742291E8F45 wds:Q114258102-BA633A3D-87BB-4E5D-A5FC-91025B4489A6
ORCID iD	https://orcid.org/0000-0002-1940-1467
ORCID iD	0000-0002-1940-1467
Dimensions author ID	01127771421.09 01207075773.77 012206625423.41 0744407313.31
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q114258102
is author of	Epigenetic determinants of ovarian clear cell carcinoma biology. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium Projecting the need for gynecologic oncologists for the next 40 years Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Frequency of germline and somatic BRCA1 mutations in ovarian cancer Growth regulation and transformation of ovarian epithelium Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer Malignant transformation of ovarian epithelium Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1 The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium MicroRNAs in endometrial cancers from black and white patients Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer BRCA2 mutations in primary breast and ovarian cancers Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma Molecular genetic features of ovarian cancer. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer Mutations of the E-cadherin gene in human gynecologic cancers. The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines Gene expression patterns that characterize advanced stage serous ovarian cancers Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas Relationship between tamoxifen use and high risk endometrial cancer histologic types BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer Common variants at 19p13 are associated with susceptibility to ovarian cancer Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software